Author: admin

Membrane Filtration Market Growth Analysis, Opportunities, Leading Manufacturers, Share, Key Segmentation, Regional Analysis, and Forecast to 2028

“MarketsandMarkets™”
Membrane Filtration Market by Application (Dairy Products, Drinks & Concentrates, Wine & Beer), Module Design (Spiral Wound, Tubular Systems, Plate & Frame and Hollow Fiber), Membrane Material, Type and Region – Global Forecast to 2028

The membrane filtration market size is projected to grow from USD 7.0 billion in 2023 to USD 9.9 billion by 2028, reflecting a CAGR of 7.2% during this period. This market is experiencing significant growth, particularly in the dairy, food and beverage, and wine and beer sectors. Several factors are driving this increased adoption. In the dairy industry, membrane filtration is becoming more prevalent to enhance the quality and shelf life of products like milk, cheese, and yogurt, while also eliminating contaminants and bacteria. Similarly, in the food and beverage sector, membrane filtration plays a crucial role in preserving the freshness and flavor of products such as juices, sauces, and soups by effectively separating solids and impurities.

Membrane Filtration Market

In the wine and beer industries, this technique is being utilized to achieve greater clarity, consistency, and quality in the final products, improving both taste and visual appeal. As consumer demand for high-quality, safe, and minimally processed food and beverages continues to rise, membrane filtration is expected to remain a vital technology, driving ongoing growth across these industries.

Membrane Filtration Market Drivers: Rising demand for premium products

The demand for membrane filtration technologies in the food and beverage sector has surged in recent years due to their crucial role in eliminating harmful microorganisms. With the increasing global demand for high-quality, safe, and value-added food products, manufacturers are adopting advanced food safety technologies. Membrane filtration is favored in the industry for its capabilities in separation, concentration, purification, and refining, while also offering high efficiency, energy savings, and environmental benefits. Key applications include dairy products, soy products, fruit and vegetable juices, brewing and sugar production, enzyme preparation, egg white concentration, and the separation and concentration of food additives like natural colors and spices.

The food and beverage industry is influenced by various trends, processes, and technologies. According to Filtration+Separation, the rise of organic farming and food production has highlighted food safety concerns, while artificial sweeteners remain a challenge for the sugar industry. Additionally, growing consumer awareness of sustainability is pushing for foods with minimal “food miles” and better waste management practices. Proper filtration technologies can meet these challenges by filtering, separating, concentrating, and clarifying liquid solutions while adhering to regulations.

In the production of wine and beer, processes such as clarification and fine filtration are essential. Beer production utilizes cold stabilization and sterile membrane filtration for sterilization. Soda production benefits from filtration to control microorganisms, clarify ingredients and final products, and filter and dechlorinate water. Compared to traditional methods, filtration offers significant advantages, such as cost-effective cold stabilization in beer production, which serves as a viable alternative to flash pasteurization, and enhanced efficiency in wine production, resulting in higher-quality wines produced in less time.

Membrane Filtration Market Opportunities: Rising demand for extended shelf life

The growing demand for extended shelf life presents a significant and expanding opportunity for the membrane filtration industry, particularly in sectors such as dairy, food and beverage, wine, and beer. As consumers seek fresher, safer, and longer-lasting products, businesses are turning to advanced preservation technologies, with membrane filtration playing a pivotal role.

Perishable dairy items like milk, yogurt, and cheese are prone to spoilage from microbial growth and enzymatic activity. Membrane filtration addresses this issue by removing spoilage-causing microbes, enzymes, and particles, thereby extending the shelf life of these products without extensive heat treatment or chemical preservatives. This approach enhances food safety while preserving nutritional value and quality, catering to health-conscious consumers.

In the food and beverage industry, membrane filtration’s precision in filtering out contaminants such as bacteria and yeast ensures prolonged freshness without compromising taste or nutritional content. In the wine and beer industries, membrane filtration aids in product stabilization by removing unwanted particles, resulting in improved clarity and stability—essential for maintaining product integrity over time.

By extending shelf life, membrane filtration not only aligns with consumer preferences but also supports industry efforts to reduce food waste. It helps minimize waste at both consumer and production levels by keeping products viable and safe for longer.

As sustainability becomes increasingly important, membrane filtration’s role in providing extended shelf life highlights its value. Manufacturers can meet consumer demands for quality and environmental responsibility by reducing reliance on artificial preservatives and additives. This convergence of consumer desires and industry sustainability goals underscores membrane filtration’s importance in addressing the growing need for long-lasting products across various industries.

What factors are driving the dominance of the reverse osmosis segment in the membrane filtration market?

Reverse osmosis is a highly effective water purification method, capable of removing nearly 99% of mineral contaminants. In the food and beverage industry, it is a widely used filtration technique that utilizes pressure to push water through a semi-permeable membrane, removing most impurities such as particles, flavors, colors, and odors. Traditional reverse osmosis systems typically feature multiple stages, with each stage filtering a portion of the wastewater produced by the previous one.

The beverage industry has also embraced reverse osmosis due to its crucial role in ensuring water quality and sterility. Water, a key ingredient in beverages, often comes from municipal sources that can contain hardness or heavy metals from transportation pipes. These impurities can affect the taste of both the water and the final products. To address this, reverse osmosis is extensively employed in beverage production.

In addition, reverse osmosis is widely used in the food sector for various applications. It plays a role in concentrating substances like egg whites, gelatin, and fruit juices, and is also used to remove bacteria and brine from meat and extract alcohol from spirits. The dairy, starch, and sugar industries also utilize reverse osmosis for a range of processes.

The Asia Pacific market dominate the membrane filtration market share.

The Asia Pacific region is witnessing a notable rise in demand for membrane filtration technology, especially in the dairy, food and beverage, and wine and beer industries. This increase is driven by factors such as a growing population, urbanization, heightened food safety awareness, and a rising preference for high-quality products. In the dairy industry, processes like ultrafiltration and microfiltration are used to improve product quality, extend shelf life, standardize compositions, and minimize waste. For the food and beverage sector, membrane filtration is crucial for clarifying liquids, concentrating flavors and nutrients, maintaining product quality, and meeting strict safety and compliance standards. In the burgeoning wine and beer market, it is essential for ensuring clarity, stability, flavor preservation, quality control, and production efficiency. As these industries expand and evolve, membrane filtration technology will increasingly be vital in addressing consumer demands and regulatory requirements.

Top Membrane Filtration Companies

Alfa Laval (Sweden), GEA Group Aktiengesellschaft (Germany), DuPont (US), Pall Corporation (US), 3M (US) and TORAY INDUSTRIES, INC.(Japan) are among the key players in the global membrane filtration market. To increase their company’s revenues and market shares, companies are focusing on launching new services, developing partnerships, and expanding their laboratory facilities. The key strategies used by companies in the food pathogen testing market include geographical expansion to tap the potential of emerging economies, strategic acquisitions to gain a foothold over the extensive supply chain, and new service launches because of extensive research and development (R&D) initiatives.

Alfa Laval (Sweden)

Alfa Laval, a prominent company known for its separators, was established in 1883 by Gustaf de Laval and Oscar Lamm Jr. in Lund, Sweden. Alfa Laval is a global leader in providing high-quality products and solutions across three main industries: energy, food & water, and marine. The company specializes in three key technologies: heat transfer, separation, and fluid handling. With an extensive range of innovative equipment, Alfa Laval makes significant contributions to various sectors, including energy & utilities, home & personal care, food & beverage, marine & transportation, pharmaceuticals & biotech, and water & wastewater.

Within its food & water division, Alfa Laval offers solutions for food processing, pharmaceuticals, biotech, vegetable oil production, breweries, dairy, personal care products, and various aspects of water treatment, both for public and industrial use. This includes a wide range of membrane filtration products, such as ultrafiltration (UF), microfiltration (MF), nanofiltration (NF), and reverse osmosis (RO), catering to the needs of the food, beverage, and water industries. Alfa Laval manufactures various types of membrane filtration systems, including flat sheet membranes and spiral elements, as well as laboratory tools.

The modular design of Alfa Laval’s membrane filtration equipment offers a high level of flexibility. Membranes can be integrated into modules, modules into loops, and loops into complete systems, allowing for customizable designs that can adapt to different process requirements and easily expand production capacity when needed. Alfa Laval serves customers in more than 100 countries worldwide, with 50 of them having their own sales teams. The company operates 42 significant manufacturing facilities, distributed across Europe, Asia, the United States, and Latin America, and maintains over 100 service centers.

DuPont (US)

DuPont is an American conglomerate that was formed by the merger of Dow Chemical and DuPont. The company later split into three divisions: DuPont, Dow Chemicals, and Corteva, with each company focusing on a specific area, such as agriculture, materials science, and specialty products. DuPont, as an organization, serves a diverse array of products and has 15 product lines, which include adhesives, advanced printing solutions, biomaterials, clean technologies, construction materials, consumer products, electronic solutions, fabric fibers and nonwovens, home garden and car care, industrial films, medical devices and materials, personal protective equipment, resins, solar, and water solutions. DuPont holds 176 brands under one umbrella.

The company operates through four major segments: electronics & industrial, water & protection, mobility & materials, and corporate. Corporate includes business activities to be divested and those that have already been divested, as well as a reconciliation of the totals for the reportable segments and the company’s totals. Membrane filters are a part of its water & protection segment. Membrane filters are used in various industrial applications, such as municipal, power, electronics, pharmaceuticals, food & beverage, mining, and oil & gas. DuPont now operates with greater agility, a clearer focus, and an enhanced ability to bring more and better solutions to customers. As one of the global leaders in purification and specialty separation technologies, the company provides quality membrane science and ion exchange solutions that produce safe drinking water for homes and communities; help industries and markets operate more effectively, efficiently, and sustainably; and make water-scarcity challenges more manageable in the food and beverages industry.

Key Questions Addressed by the Membrane Filtration Market Report:

Which region is projected to account for the largest share in the membrane filtration market?

What is the current size of the global membrane filtration market?

Which are the key players in the market?

What are the factors driving the membrane filtration market?

Which segment by type accounted for the largest membrane filtration market share?

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=68840418

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/membrane-filtration-market-68840418.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Membrane Filtration Market Growth Analysis, Opportunities, Leading Manufacturers, Share, Key Segmentation, Regional Analysis, and Forecast to 2028

Agricultural Biologicals Market Growth Analysis, Opportunities, Leading Manufacturers, Share, Key Segmentation, Regional Analysis, and Forecast to 2029

“MarketsandMarkets™”
Agricultural Biologicals Market by Type (Biocontrol, Biostimulants, Biofertilizers), Source (Microbials, Macrobials, Semiochemicals, Natural Products), Mode of Application (Foliar Spray, Seed Treatment, Soil Treatment)—Global Forecast to 2029

The global agricultural biologicals market is estimated at USD 16.7 billion in 2024 and is projected to reach USD 31.8 billion by 2029, at a CAGR of 13.8% during the forecast period. While research in biotechnology and microbes has yielded improved efficiencies in products, it has also increased specificity. Biologicals are becoming more attractive to farmers, as enhancements in efficiencies and reliability have been carried out on them. Farmers are beginning to realize that the overall agricultural productivity of their farms in the long run depends on how well the health of the soil is maintained. Agricultural biologicals, which includes elements like bio-fertilizers and biostimulants, maintain the soil’s fertility and friendly microbial activity to make the crops healthier and yields better.

Agricultural Biologicals Market

Downnoad PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100393324

By crop type, the fruits & vegetables segment is estimated to hold the largest market share during the forecast period.

Biologicals have broad applications in fruits and vegetables against the unique, intensive pest and disease pressures characterizing these crops. Most often, fruits and vegetables are more predisposed to different pests and diseases than other crops; thus, applying biologicals offers a sustainable and environmentally friendly alternative to the conventional use of chemical products in their control. The former category includes useful microbes and other natural compounds with targeted control, reduced chemical residue, and improved soil health. These also link well to contemporary consumer demand for safer and organic produce. Moreover, the high value of fruits and vegetables requires investment in biologicals to help ensure optimal yields and quality.

By mode of application, seed treatment is estimated to grow at the highest CAGR during the forecast period.

Seed treatment is expected to be the largest application area, as it will grow at the highest CAGR in the agricultural biologicals market. This is explained by its enhanced adoption as a precautionary measure in order to improve health and yield of crops. Several factors drive this growth. For instance, seed treatments protect seeds from diseases, pests, and environmental stresses right from the beginning, improving the germination rate and making the seedlings stronger. Moreover, raising awareness and demand for sustainable and organic farming have also provided an enhanced scope for biological seed treatment methods that would reduce chemical usage and minimize the impact on the environment. As farmers become more aggressive in searching out better, cleaner solutions, greater adoption of sophisticated biological seed treatments is likely to further accelerate segment growth.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=100393324

By source, the natural products segment is estimated to hold second position in terms of market share in the agricultural biologicals market.

The natural products in the agricultural biologicals market will hold second place in by source segment. Natural products are derived from plants, animals, or microorganisms and help in the regulation of pests, enrichment of health by soil, and management for diseases without such drawbacks as synthetic chemicals. Their popularity is gaining momentum toward rising demands from residue-free and organic produce consumers, regulatory support to sustainable practices, and environmental concerns. Although other biological and synthetic methods also contribute to the market, natural products take a major constituent place in integrated pest management and soil fertility programs—therefore, they do hold a sort of central place within the agricultural biologicals market.

The agricultural biologicals market in the Asia pacific region is expected to grow constantly during the forecast period.

Rising demand for food, an enormous and dynamic agricultural base, and investments in the adoption of modern technologies for farming are heavy and override the agriculture development in this region. Agricultural biologicals thus find increasing adoption in countries like China, India, and South East Asian countries for the purpose of enhancing farm productivity as well as sustainability. Other drivers include increasing consumer demand for organically grown and residue-free crops, government encouragement of sustainable methods of farming, and growing recognition of the potential of biologicals for environmentally friendly benefits as compared to synthetic chemicals. Likewise, growing interest in improving soil quality and the resultant surge in the adoption of ecofriendly pest control methodologies are increasing the popularity of biological products. The outlook for the Asia-Pacific market thus indicates significant growth and therefore bears greatly on biologicals in a changing agricultural landscape.

Top Agricultural Biologicals Companies

Key players in the agricultural biologicals market are BASF SE (Germany), Syngenta Group (Switzerland), Bayer AG (Germany), FMC Corporation (US), Corteva (US), UPL (India), Nufarm (Australia), Novonesis (Denmark), Lallemand Inc (Canada), Mosaic (US), Rovensa Next (Spain), Sumitomo Chemical Co., Ltd (Japan), SEIPASA, S.A. (Spain), Koppert (Netherlands), and Gowan Company (US).

BASF SE (Germany)

BASF SE is one of the top chemical producers with six segments that make up 11 divisions. These are: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. Its Chemicals segment has the divisions of Petrochemicals and Intermediates. In the Materials segment, there are Performance Materials and Monomers. Industrial Solutions is comprised of the Dispersions & Resins and Performance Chemicals divisions, while Surface Technologies is comprised of the Catalysts and Coatings divisions. Nutrition & Care is made up of the Care Chemicals and Nutrition & Health divisions. The fungicides, herbicides, insecticides, and biological solutions – as well as seed and seed treatment products – come from the Agricultural Solutions business unit. BASF BioSolutions are very good companions for organic crop protection and conventional crop protection. They offer bio-fungicides, bio-insecticides, and bio seed treatment, all drawing on natural defenses like beneficial nematodes, microorganisms, plant extracts, and pheromones. BASF SE is operative in more than 90 countries around the world; the company also has six Verbund sites and 241 production sites.

Syngenta Group (Switzerland)

Based in Switzerland, Syngenta Group is the leading global crop protection company with 150 subsidiaries around the world. Being one of the largest agriculture technology enterprises globally with 250 years of heritage, it has about 60,000 people working in more than 100 countries. The vision of the group is to change the face of agriculture with science-based breakthroughs to produce more food with greater care for people and the planet, increasing productivity while improving food quality, addressing climate change, and preserving natural resources. Long-term close collaboration with farmers has made Syngenta Group a truly regenerative agriculture advocate, which is the holistic and integrative process for food system transformation aimed at promoting soil health, protecting natural resources, and biodiversity preservation through strengthened farm productivity and resilience. Syngenta Group engages in four major business units: Syngenta Crop Protection, Syngenta Seeds, ADAMA, and Syngenta China. Together, these entities offer the most up-to-date solutions to the wide needs of their clientele all over the world.

Schedule a call with our Analysts to discuss your business needs: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=100393324

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/agricultural-biological-market-100393324.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Agricultural Biologicals Market Growth Analysis, Opportunities, Leading Manufacturers, Share, Key Segmentation, Regional Analysis, and Forecast to 2029

CD Antigen Cancer Therapy Market 2024: Trends, Innovations, and Growth Outlook

“CD Antigen Cancer Therapy Market”
CD Antigen Cancer Therapy Market is valued at US$ 26.2 Bn in 2023, and it is expected to reach US$ 41.8 Bn by 2031, with a CAGR of 6.21% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global CD Antigen Cancer Therapy Market – Type of CD Antigen Targeted (CD19, CD20, CD30, CD33, CD38, CD70, Others), By Therapy Type [Monoclonal Antibodies (mAbs), Antibody-Drug Conjugates (ADCs), Chimeric Antigen Receptor (CAR) T-cell Therapy, Bi-specific T-cell Engagers (BiTEs), Radioimmunotherapy, Immunotoxins], By Cancer Type (Leukemia, Lymphoma, Multiple Myeloma, Breast Cancer, Lung Cancer, Prostate Cancer, Others), By End User (Hospitals, Specialty Clinics, Cancer Treatment Centers, Research Institutes), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global CD Antigen Cancer Therapy Market is valued at US$ 26.2 Bn in 2023, and it is expected to reach US$ 41.8 Bn by 2031, with a CAGR of 6.21% during the forecast period of 2024-2031.

CD antigen cancer therapy is a specialized method of treating cancer by targeting proteins found on cancer cells’ surfaces, called CD antigens. The CD antigen cancer therapy market is growing rapidly worldwide due to the rising cancer incidence and the expansion of R&D efforts. Several groups worldwide are researching and coordinating their efforts to find better ways to use cancer CD antigen cancer therapy. Targeted techniques offered by CD antigen cancer medicines can potentially enhance treatment outcomes, boosting market expansion. This has led to a dramatic increase in the budgets allocated to cancer research and the development of novel treatment methods. However, the industry is expected to be hindered by regulatory hurdles regarding approving and utilizing CD antigen cancer therapy. Also, the market is expected to slow down throughout the projected period due to specific manufacturing and pharmacological challenges related to this CD antigen cancer therapy development.

Get Free Access to Demo Report, Excel Pivot and ToC : https://www.insightaceanalytic.com/request-sample/2644

List of Prominent Players in the CD Antigen Cancer Therapy Market:

  • Novartis AG
  • Roche Holdings AG
  • Bristol Myers Squibb Company
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Johnson & Johnson
  • Amgen Inc.
  • AbbVie Inc.
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited
  • Seattle Genetics Inc.
  • Biogen Inc.
  • Celgene Corporation
  • Genmab A/S
  • Immunomedics Inc.
  • Others

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:

Drivers-

The rising incidence of cancer in general and targeted therapies, in particular, are propelling the CD antigen cancer therapy industry forward. Recent progress in immunotherapy and biotechnology has resulted in the creation of novel CD antigen-targeting medications. Market expansion is also driven by legislative frameworks that support industry and significant investments in research & development. Additionally, CD antigen therapies have shown promising results in clinical studies, and there is a growing need for personalized therapy, which contributes to the expansion of the market.

Challenges:

There are several obstacles in the CD antigen cancer therapy industry, including complicated manufacturing methods, expensive production and development costs, and strict regulatory regulations. Conducting clinical trials to establish the safety of CD antigen cancer therapy is costly and time-consuming. Another major obstacle is the wide range of possible side effects and patient reactions. Alternative cancer treatments and problems with intellectual property also affect market expansion. For these reasons, it is difficult for novel therapies to enter the market on a large scale.

Regional Trends:

The North American CD antigen cancer therapy market is anticipated to register a major market share in revenue. It is projected to grow at a high CAGR in the near future due to the rising frequency of cancers, significant funding for research and development of targeted therapies, and a heavy focus on precision medicine and customized oncology. Besides, Europe had a substantial share in the market because of rapid urbanization, enhanced healthcare facilities, and abundant discretionary income; escalating rates of breast cancer because of unhealthy lifestyle choices, including less exercise and more alcohol use, resulted in the dramatic rise of CD antigen cancer therapy market in this region.

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/enquiry-before-buying/2644

Recent Developments:

  • In March 2024, Bristol Myers Squibb received FDA approval for its chimeric antigen receptor (CAR) T cell therapy; Breyanzi, a CD19-directed CART therapy, for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least two prior lines of therapy.
  • In 2023, Gilead Sciences, Inc. received FDA approval for its Trodelvy, Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer and metastatic urothelial cancer to treat inoperable locally advanced or metastatic breast cancer in adults.

Segmentation of CD Antigen Cancer Therapy Market-

By Type of CD Antigen Targeted-

  • CD19
  • CD20
  • CD30
  • CD33
  • CD38
  • CD70
  • Others

By Therapy Type-

  • Monoclonal Antibodies (mAbs)
  • Antibody-Drug Conjugates (ADCs)
  • Chimeric Antigen Receptor (CAR) T-cell Therapy
  • Bi-specific T-cell Engagers (BiTEs)
  • Radioimmunotherapy
  • Immunotoxins

By Cancer Type-

  • Leukaemia
  • Lymphoma
  • Multiple Myeloma
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Others

By End-User-

  • Hospitals
  • Specialty Clinics
  • Cancer Treatment Centers
  • Research Institutes

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2644

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: CD Antigen Cancer Therapy Market 2024: Trends, Innovations, and Growth Outlook

Anastomosis Device Market worth $4.4 billion by 2027

“The global anastomosis devices market in terms of revenue was estimated to be worth $3.0 billion in 2022 and is poised to reach $4.4 billion by 2027, growing at a CAGR of 8.3% from 2022 to 2027”
Browse 289 market data Tables and 42 Figures spread through 305 Pages and in-depth TOC on “Anastomosis Device Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable, Automated), and Surgical Sealants and Adhesives, Application (CVDs, GI Surgeries) and End Users – Global Forecast to 2027

Anastomosis Device Market is projected to grow from USD 3.0 billion in 2022 to USD 4.4 billion by 2027, at a CAGR of 8.3% from 2022 to 2027 according to a new report by MarketsandMarkets™. The increasing incidence of target diseases and the subsequent growth in the number of surgical procedures, the growing demand for minimally invasive surgeries, and technological advancements are the major factors driving the market’s growth. Emerging economies such as China, Japan, and India are providing profitable opportunities for the players operating in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5343963

“Surgical Staplers segment accounted for the largest share of the anastomosis devices market, by product.”

The anastomosis device market is segmented into surgical staplers, surgical sutures, and surgical sealants & adhesives. In 2021, the surgical staplers segment accounted for the largest share of the market. The surgical staplers market is further segmented into manual and powered surgical staplers. In 2021, the manual surgical staplers segment accounted for the largest share of the surgical staplers market. The large share of this segment can be attributed to the wide range of advantages associated with these devices, such as ease of use, minimal risk of complications like blood loss/leakage, shorter operating time, and reduced hospital costs.

“Cardiovascular & Thoracic Surgery accounted for the largest share in the market, by application.”

The anastomosis device market has been segmented into cardiovascular & thoracic surgery, gastrointestinal surgery, orthopaedic surgery, gynaecological surgery, and other applications. In 2021, the cardiovascular & thoracic surgery segment accounted for the largest share of the temperature monitoring market. Market growth can largely be attributed to the many cardiovascular surgeries performed across the globe because of the high incidence of cardiovascular disease (CVD), the increasing number of coronary and percutaneous cardiology interventions, and the growing adoption of anastomosis devices in these surgical procedures.

“Hospitals segment accounted for the largest share in the market, by end users.”

The anastomosis device market has been segmented into hospitals, ambulatory surgery centers, and other end users. In 2021, hospitals are estimated to be the largest end users of the market. The large share of this segment can be attributed to the increasing number of complex surgeries performed in hospitals, the growing geriatric population, favourable reimbursement policies for hospital treatments, and the growing number of new hospitals, especially in emerging countries.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=5343963

“North America is the largest regional market for anastomosis devices.”

The global anastomosis device market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the market. The large share of North America in the global market can be attributed to the positive reimbursement scenario in the US, the rising incidence of cancer, and the implementation of a new funding model for Canadian hospitals.

The key players in anastomosis device market are Johnson & Johnson (US), Medtronic Plc (Ireland), B. Braun Melsungen (Germany), Intuitive Surgical Inc. (US), Boston Scientific Corporation (US), Artivion, Inc. (US), Smith & Nephew Plc (UK), Becton, Dickinson and Company (US), CONMED Corporation (US), Advanced Medical Solutions Group Plc (UK), Baxter International, Inc. (US), Teleflex (US), Meril Life Sciences (India), Surgical Specialties Corporation (US), Péters Surgical (France), DemeTECH Corporation (US), Purple Surgical (UK), Internacional Farmacéutica S.A. de C.V. (Mexico), BioSintex (Romania), Lotus Surgicals (India), Mellon Medical (Netherlands), and Frankenman International (China), EndoEvolution (US), Welfare Medical (UK) and Unisur Lifecare (India).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=5343963

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/anastomosis-device-market-worth-4-4-billion-by-2027–exclusive-report-by-marketsandmarkets-301613042.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Anastomosis Device Market worth $4.4 billion by 2027

Cancer-Focused Genetic Testing Service Market 2024: Trends, Growth Insights, and Forecast

“Cancer-focused Genetic Testing Service Market”
Cancer-focused Genetic Testing Service Market is valued at US$ 7.82 Bn in 2023, and it is expected to reach US$ 14.41 Bn by 2031, with a CAGR of 8.2% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Cancer-focused Genetic Testing Service Market – (By Test Type (Chromosome Testing, DNA Testing, Direct DNA Testing, Indirect DNA Testing, Biochemical Genetic Testing), By Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Bladder Cancer, Kidney Cancer, Other), By Service Provider (Hospital, Specialty Clinics, Diagnostic Laboratories, Specialized Cancer Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Cancer-focused Genetic Testing Service Market is valued at US$ 7.82 Bn in 2023, and it is expected to reach US$ 14.41 Bn by 2031, with a CAGR of 8.2% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC : https://www.insightaceanalytic.com/request-sample/2622

The purpose of cancer-specific genetic testing is to analyze a person’s genetic material in order to detect gene alterations that have the potential to enhance the chance of getting cancer. The provision of these services is essential in order to facilitate the development of individualized treatment strategies, early diagnosis, and prevention actions for genetic profiles. The next-generation sequencing (NGS) technique is widely used to conduct a thorough and speedy study of a large number of genes. It is projected that there will be a rise in the demand for genetic testing that is intended to particularly target cancer on a worldwide scale. This development may be attributed to a number of factors, comprising the rising prevalence of cancer, the growing awareness of the need for early detection, and the breakthroughs that have been made in genetic testing. With the use of genetic testing and precision medicine in clinical settings, the sector is seeing significant growth. Despite its growing promise, the industry of cancer-specific genetic testing is confronted with challenges brought on by ethical and regulatory considerations. It is possible that limits on patient privacy and the use of genetic data will act as a barrier to the development and implementation of innovative diagnostic tools. A number of factors, including inherited prejudice and the psychological effect of test findings, contribute to the complexity of the problem.

List of Prominent Players in the Cancer-focused Genetic Testing Service Market:

  • Cleveland Clinic
  • Fortis Healthcare
  • KIMS Hospitals
  • Rush University Medical Center
  • The Johns Hopkins Hospital
  • Bridgeport Hospital
  • Greenwich Hospital
  • Lawrence Memorial Hospital
  • Westerly Hospital
  • Yale New Haven Hospital
  • Northeast Medical Group

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:

Drivers-

The rising global incidence of cancer is fueling the need for specialized genetic testing services specifically designed for the identification of cancer. Timely identification and tailored treatment are essential in light of the increasing incidence of cancer. Genetic testing services can detect genes that increase the chance of developing cancer, allowing for targeted treatment and preventive measures. The utilization of modern technologies such as next-generation sequencing (NGS) has greatly enhanced the accuracy and effectiveness of these services. Next-generation sequencing (NGS) efficiently examines many genes, uncovering an individual’s genetic composition and susceptibility to cancer, thus enhancing the accessibility and cost-effectiveness of genetic testing. This technical innovation has played a crucial role in promoting the expansion of the cancer-specific genetic testing industry.

Challenges:

Overcoming the social and ethical problems related to genetic testing is a major barrier to the growth of the worldwide business. The issue of genetic discrimination presents complex moral and ethical challenges since the progress in genetic testing technology gives rise to significant concerns regarding its use, execution, and the understanding of its outcomes. Moreover, a lack of widespread comprehension of genetics might result in the stigmatization and misinterpretation of intricate genetic test outcomes. These problems emphasize the necessity of thorough education and ethical principles to guarantee appropriate utilization and widespread approval of genetic testing. The delicate equilibrium between technical advancement and ethical deliberations continues to pose a crucial obstacle to the industry’s expansion.

Regional Trends:

North America is leading the market because of its strong healthcare infrastructure, technological progress, and high incidence of cancer. Key industry leaders prioritize the expansion of genetic testing capabilities to provide comprehensive solutions for customized cancer treatment and prevention. The FDA’s rigorous regulatory supervision promotes confidence and acceptance among healthcare practitioners and patients. The Asia-Pacific area is at the forefront of the market for genetic testing services focusing on cancer. This is due to its rapid growth rates, which are driven by substantial investments in healthcare and an increasing number of cancer cases. These countries experience advantages from the growth of healthcare spending, a growing middle-class population, and a rising understanding of the advantages of genetic testing for cancer treatment.

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/enquiry-before-buying/2622        

Segmentation of Cancer-focused Genetic Testing Service Market-

By Test Type-

  • Chromosome Testing
  • DNA Testing
  • Direct DNA Testing
  • Indirect DNA Testing
  • Biochemical Genetic Testing

By Cancer Type-

  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Bladder Cancer
  • Kidney Cancer
  • Other

By Service Provider-

  • Hospital
  • Specialty Clinics
  • Diagnostic Laboratories
  • Specialized Cancer Institutes

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2622

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cancer-Focused Genetic Testing Service Market 2024: Trends, Growth Insights, and Forecast

Diagnostic Imaging Market worth $34.6 billion | MarketsandMarkets

“Siemens Healthineers (Germany) launched a new MRI system for mobile use. The Magnetom Viato.Mobile system is equipped with latest advancements and can be used anywhere.”
The diagnostic imaging industry is poised for remarkable advancements in the near future, driven by groundbreaking technologies and evolving healthcare needs.

Diagnostic Imaging Market in terms of revenue was estimated to be worth $26.5 billion in 2023 and is poised to reach $34.6 billion by 2028, growing at a CAGR of 5.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The major factors driving the growth of this market include the launch of technologically advanced products by the key players and increasing prevalence of chronic diseases.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=411

Mammography systems segment to register significant growth rate over the forecast period of 2023-2028.

Based on the product, the global diagnostic imaging market is segmented into CT scanners, X-ray imaging systems, ultrasound systems, MRI systems, nuclear imaging systems, and mammography systems. The mammography systems segment is anticipated to register the highest growth rate over the forecast period. The CT scanners segment accounted for the highest share of the diagnostic imaging market in 2022.

Cardiology application segment accounted for the largest share of the CT scanners market, by application in 2022.

Based on application, the diagnostic imaging market is segmented into MRI systems – brain and neurological MRI, spine and musculoskeletal MRI, pelvic and abdominal MRI, vascular MRI, cardiac MRI, ultrasound systems – radiology/general imaging, cardiology, obstetrics/gynecology, vascular applications, urology, other applications, X-ray imaging systems – general radiography, fluoroscopy, dentistry, CT scanners- cardiology, oncology, neurology, and other applications, nuclear imaging systems – cardiology, oncology, neurology, and other applications, and mammography systems. Cardiology application segment accounted for the largest share of the market in 2022 and is also expected to grow at the highest CAGR during the forecast period.

Factors such as the introduction of novel software and rising adoption of high-end instruments in end user facilities drive the growth of the market.

The hospitals segment accounted for the largest share of the diagnostic imaging market, by end user, in 2022

Based on end user, the global diagnostic imaging market is segmented into hospitals, diagnostic imaging centers, and other end users. The hospitals segment accounted for the largest share of the market in 2022. Significant rise in the number of hospitals and rising old-age population are driving the growth of this segment.

The Asia Pacific market to register the highest growth in the market during the forecast period

The Asia Pacific diagnostic imaging market is anticipated to register the highest growth from 2023 to 2028. Major players in the market are focusing on expanding their manufacturing capabilities in the APAC. This region is consistently witnessing a rise in the adoption of high-end equipment. Improvements in healthcare systems and government initiatives for modernizing the healthcare infrastructure are offering significant growth opportunities for the key players.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=411

Diagnostic Imaging Market Dynamics:

Drivers:

  1. Growing geriatric population and subsequent rise in chronic diseases

Restraints:

  1. High cost of diagnostic imaging systems

Opportunities:

  1.  Growth opportunities in emerging countries

Challenge:

  1. Shortage of trained professionals

Key Market Players:

As of 2022, prominent players in the diagnostic imaging market are Siemens Healthineers (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan) among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=411

Diagnostic Imaging Market Advantages:

  • Early Detection and Diagnosis: Diagnostic imaging technologies, such as X-rays, MRI, CT scans, and ultrasound, enable healthcare providers to detect diseases and medical conditions at their earliest stages. This allows for prompt intervention and treatment, potentially saving lives and improving outcomes.
  • Non-Invasive: Most diagnostic imaging procedures are non-invasive or minimally invasive, reducing patient discomfort and the risk of complications compared to traditional surgical exploratory methods.
  • Precision and Accuracy: Diagnostic imaging provides detailed and precise images of the body’s internal structures, aiding in accurate diagnosis and treatment planning. This precision is particularly crucial in areas like oncology, cardiology, and neurology.
  • Monitoring Disease Progression: Imaging techniques allow healthcare professionals to monitor the progression of diseases and the effectiveness of treatments over time. This ongoing assessment can guide adjustments to treatment plans for better patient outcomes.
  • Reduced Need for Exploratory Surgery: Diagnostic imaging helps eliminate the need for exploratory surgeries in many cases, reducing healthcare costs, patient recovery time, and potential complications.
  • Guidance for Minimally Invasive Procedures: Imaging technologies play a critical role in guiding minimally invasive surgical procedures, such as laparoscopy and endoscopy, increasing their precision and safety.
  • Patient-Friendly: Advances in imaging technology have led to shorter scan times, reduced radiation exposure, and improved patient comfort, making the diagnostic process more patient-friendly.
  • Research and Development: The diagnostic imaging market drives innovation and research in medical imaging technologies. This continuous advancement leads to improved diagnostic capabilities and new applications in healthcare.
  • Personalized Medicine: Diagnostic imaging facilitates the trend toward personalized medicine by tailoring treatments to an individual’s unique anatomy and pathology, optimizing therapy outcomes.
  • Global Impact: Diagnostic imaging plays a vital role in global healthcare by assisting in disease control, epidemiological studies, and healthcare infrastructure development, especially in remote or underserved areas.

In summary, the diagnostic imaging market’s advantages encompass early disease detection, non-invasiveness, precision, monitoring capabilities, cost-effectiveness, patient-friendliness, research opportunities, and its contribution to personalized medicine and global healthcare. These benefits make diagnostic imaging a cornerstone of modern healthcare practices.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/diagnostic-imaging-market-worth-34-6-billion–marketsandmarkets-301930231.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Diagnostic Imaging Market worth $34.6 billion | MarketsandMarkets

Biopharmaceutical Processing Equipment and Consumables Market 2024: Key Trends, Growth Insights, and Forecast

“Biopharmaceutical Processing Equipment and Consumables Market”
Biopharmaceutical Processing Equipment and Consumables Market is valued at US$ 44.1 Bn in 2023, and it is expected to reach US$ 85.7 Bn by 2031, with a CAGR of 8.84% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Biopharmaceutical Processing Equipment and Consumables Market– (By Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine Manufacturing, mAb Production, Cell and Gene Therapy Production and Others)), By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Biopharmaceutical Processing Equipment and Consumables Market is valued at US$ 44.1 Bn in 2023, and it is expected to reach US$ 85.7 Bn by 2031, with a CAGR of 8.84% during the forecast period of 2024-2031. 

Biopharmaceutical processing equipment and consumables include the many resources and parts needed for producing and handling biological goods. These consumables are essential to biological manufacturing procedures when it comes to the preparation, storage, and filtration of biological substances, including medication, monoclonal antibodies, novel proteins, and gene therapy. Technological breakthroughs, a rising incidence of long-term illnesses, and the increasing acceptance of personalized treatment are driving the need for biopharmaceuticals. Specialized tools and supplies are needed to produce and manufacture biopharmaceuticals, including gene treatments and vaccinations. Because producers are trying to keep up with the increasing demand, the market for consumables for biopharmaceutical processing equipment has surged. A significant increase in the need for biopharmaceuticals is anticipated to propel the worldwide industry for consumable equipment used in biopharmaceutical processing in the years ahead.

Furthermore, the rising incidence of long-term diseases, including cancer, rare genetic disorders affecting a wide range of uncommon diseases, and others, is a major force propelling the consumable biopharmaceutical processing equipment market forward. Several factors drive market expansion, including rising cancer rates, ethical acceptance of biopharmaceutical processing equipment, and more government support. However, the poor retention of skilled workforce is a limitation on the growth of the worldwide biopharmaceutical processing equipment consumable market, making it one of the most challenging markets to maintain a stable workforce.

Get Free Access to Demo Report, Excel Pivot and ToC : https://www.insightaceanalytic.com/request-sample/2634

List of Prominent Players in the Biopharmaceutical Processing Equipment and Consumables Market:

  • 3M Company
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc
  • Repligen Corporation
  • Sartorius AG
  • Merck KGaA
  • Eppendorf AG
  • Solaris Biotechnology Srl
  • Other Prominent Players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:

Drivers:

The growing demand for biopharmaceutical processing equipment and consumables market is fueled by technological development. Biopharmaceutical production processes’ productivity, precision, and security have increased with the introduction of disposable technology, robotics, and sophisticated ingredients. These developments resulted in cheaper operating expenses, more output, and a decreased danger of pollution. As long as producers keep spending money on R&D, new and inventive technology should be introduced that will help the worldwide biopharmaceutical processing equipment consumable industry manufacturing.

Challenges:

The prime challenges are restrictions on usability and compliance, a shortage of competent individuals, and a lack of norms and protocol because of lockdowns and isolation in emerging countries, which is predicted to slow the growth of the biopharmaceutical processing equipment and consumables market. The reliability and effectiveness of biopharmaceutical products depend on the consumables used in biopharmaceutical processing equipment, which have constant levels of performance and quality. It might be difficult to keep up rigorous standards of quality control during the entire production process, especially when dealing with complicated and configurable essentials.

Regional Trends:

The North American biopharmaceutical processing equipment and consumables market is anticipated to register a major market share in terms of revenue. It is projected to grow at a high CAGR in the near future because of the rising number of cases of cardiovascular disease, massive investments in R&D, novel technologies, new government programs, and growing healthcare costs. Besides, Europe had a substantial share in the market because of many things, including a larger patient population, more infectious illness cases, more people knowing about therapy, more cancer cases, and more people involved in research and development.

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/enquiry-before-buying/2634

Recent Developments:

  • In July 2024, Thermo Fisher Scientific declared that its initial electron microscopic display facility would operate in Taiwan. Situated in the center of the region’s electronic production sector, this cutting-edge institution, known as a NanoPort, is built to accommodate the region’s expanding demand for sophisticated analysis tools and knowledge. The brand-new building will collaborate with local semiconductor clients and is currently among the six Thermo Fisher NanoPort locations globally.
  • In July 2024, Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”) released its Ecological Report, which outlines the organization’s significant accomplishments and demonstrates the scope and complexity of its environmental sustainability strategy.

Segmentation of Biopharmaceutical Processing Equipment and Consumables Market

Biopharmaceutical Processing Equipment and Consumables Market- By Product Type

  • Filtration Systems
  • Chromatography Equipment and Consumables
    • Consumables
    • Equipment
    • Bioreactors
      • Reusable Bioreactors
      • Disposable/Single-use Bioreactors
      • Cell Culture Products
        • Cell Culture Media
          • Cell Culture Media, by Physical Form
            • Dry Powder Media
            • Liquid Media
        • Cell Culture Media, by Type
          • Off-the-Shelf Media
          • Custom Media
        • Cell Culture Media, by Source
          • Chemically Defined Media
          • Natural Media
  • Reagents and Supplements
  • Cell and Cell Lines
  • Serum
  • Mixing Systems
  • Bioprocessing Containers
  • Sterilizers
  • Centrifuges
  • Incubators
  • Shakers
  • Biosafety Cabinets
  • Other Equipment and Consumables
  • Services

Biopharmaceutical Processing Equipment and Consumables Market- By Application

  • Commercial Bioproduction
  • Vaccine Manufacturing
  • mAb Production
  • Recombinant Protein Production
  • Cell and Gene Therapy Production
  • Research Bioproduction

Biopharmaceutical Processing Equipment and Consumables Market- By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Academia and Research Institutes

Biopharmaceutical Processing Equipment and Consumables Market- By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2634

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Biopharmaceutical Processing Equipment and Consumables Market 2024: Key Trends, Growth Insights, and Forecast

Interactive Patient Care Market / Interactive Patient Engagement Solutions Market worth $300 million by 2027 – Exclusive Report by MarketsandMarkets™

“[185 Pages Report] The global interactive patient care market is projected to reach USD 300 million by 2027 from USD 146 million in 2022, at a CAGR of 15.5%.”
Interactive Patient Care Market / Interactive Patient Engagement Solutions Market is projected to reach USD 300 million by 2027 from USD 146 million in 2022, at a CAGR of 15.5%

Interactive Patient Care Market / Interactive Patient Engagement Solutions Market is projected to reach USD 300 million by 2027 from USD 146 million in 2022, at a CAGR of 15.5% according to a new report by MarketsandMarkets™. The growth of this market is driven by the need for the adoption of improved interactive patient engagement solutions, a growing number of collaborations and partnerships between stakeholders, and favorable government regulations and initiatives to promote the adoption of these solutions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164064021

However, high infrastructural requirements and implementation costs and data security concerns are expected to restrain the growth of this Interactive Patient Care Market to a certain extent during the forecast period.

“Hardware segment is expected to grow at the highest rate during the forecast period”

Based on product, the market is segmented into hardware and software. The hardware segment accounted for the largest share of the Interactive Patient Care Market in 2021. This segment is also projected to register the highest CAGR during the forecast period. This can be attributed to the rising development of TV-based solutions and the increased adoption of in-room televisions by hospitals.

“The inpatient solutions segment is expected to account for the largest share of the Interactive patient engagement solutions market in 2021”

Based on type, the market is segmented into inpatient and outpatient solutions. The inpatient solutions segment accounted for the largest share of the Interactive Patient Care Market in 2021. The large share of this segment can be attributed to the need for improved patient care and favorable government initiatives for the adoption of these solutions.

“Hospitals segment in the end users is expected to account for the largest share of the global Interactive patient engagement solutions market”

Based end users, the market is segmented into hospitals, clinics, and other end users. In 2021, the hospitals segment accounted for the largest share of the Interactive Patient Care Market / Interactive Patient Engagement Solutions Market and expected to grow at the highest CAGR during the forecast period Rising demand for IT tools to tackle the demand of hospital staff and the increasing demand for effective communication tools are driving the growth of this end-user segment.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=164064021

“North America to dominate the Interactive patient engagement solutions market in 2022”

North America accounted for the largest share of the Interactive Patient Care Market / Interactive Patient Engagement Solutions Market in 2021 and also expected to grow at the highest CAGR during the forecasted period. Favorable government initiatives, the rising prevalence of chronic diseases, and rising awareness about digital healthcare products are some of the key factors responsible for the large share and high growth rate of this market.

Prominent players in this Interactive Patient Care Market / Interactive Patient Engagement Solutions Market are:

GetWellNetwork (US), Epic Systems Corporation (US), SONIFI Health (US), Barco (Belgium), Sentrics (US), Advantech Co., Ltd. (Taiwan), Aceso Interactive Inc. (US), HealthHub Patient Engagement Solutions (Canada), Lincor, Inc. (US), eVideon (US), Remedi Complete Medical Solutions (Taiwan), i3solutions (Canada), PDi Communication Systems, Inc. (US), BEWATEC ConnectedCare GmbH (Germany), Hôpitel Inc. (Canada), Hospedia (UK), Onyx Healthcare Inc. (US), ClinicAll (US), ARBOR Technology Corp. (Taiwan), Healthcare Information, LLC (US), Oneview Healthcare (Ireland), Siemens (Germany), Vecoton (China), pCare (US), and Medix-Care GmbH (Germany).

These players are increasingly focusing on product launches, expansions, acquisitions, and partnerships to expand their product offerings in the interactive patient engagement solutions market.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=164064021

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/interactive-patient-care-market–interactive-patient-engagement-solutions-market-worth-300-million-by-2027–exclusive-report-by-marketsandmarkets-301590067.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Interactive Patient Care Market / Interactive Patient Engagement Solutions Market worth $300 million by 2027 – Exclusive Report by MarketsandMarkets™

Base Editing Market 2024: Trends, Innovations, and Growth Forecast

“Base Editing Market”
Base Editing Market is valued at US$ 273.1 Mn in 2023, and it is expected to reach US$ 904.8 Mn by 2031, with a CAGR of 16.4% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Base Editing Market – (by Product (Platform, Reagents & Kits, Plasmids, Base Editing Libraries), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application, End-User, Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Base Editing Market is valued at US$ 273.1 Mn in 2023, and it is expected to reach US$ 904.8 Mn by 2031, with a CAGR of 16.4% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC : https://www.insightaceanalytic.com/request-sample/2619

Base editing is a method by which cells may modify the genetic algorithm at particular points in a genomic. Base editing (BE) presents possible treatment approaches for many illnesses. Treating genetic changes linked to immune problems and persistent medical conditions like diabetes, heart disease, and some cancers has shown great promise when it comes to base editing. Furthermore, extensive screening and functionality investigation of specific nucleotide variations linked to cancer is made possible by base editing detector archives. Globally, the incidence of cancer cases is increasing, which increases the need for new treatments. However, government health organizations set up surveillance systems to track the spread, new cases, and trends of base editing. These initiatives are useful for tracking the prevalence of respiratory infections, locating outbreaks, and enforcing preventative measures. Innovation in diagnostic tools for base editing is facilitated by government financing for related research.

List of Prominent Players in the Base Editing Market:

  • Danaher Corporation
  • Merck KGaA
  • Revvity
  • Maravai LifeSciences
  • GenScript
  • Beam Therapeutics
  • Intellia Therapeutics, Inc.
  • Cellectis
  • Bio Palette Co., Ltd
  • Addgene
  • Synthego
  • EdiGene, Inc.
  • Shape TX
  • Pairwise
  • ProQR Therapeutics
  • QI-Biodesign
  • KromaTiD, Inc.
  • GenKOre
  • Other Market Players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:

Drivers-

The growing demand for base editing is largely fueled by the increasing prevalence of genetic illnesses worldwide. As recognition of the genomic bases of numerous illnesses expands, there is an increasing demand for specific and focused therapies. Due to its ability to correct specific genetic mutations without producing unwanted side effects, base editing is a revolutionary method in the area of personalized medicine. Since the demand for personalized medicine to handle genetic illnesses better is driving up demand, the industry is seeing significant acceptance and expenditure on base editing techniques.

Challenges:

The main obstacles include stringent laws, a lack of qualified personnel, and a lack of customs and etiquette as a result of lockdowns and isolation in developing nations, which are expected to limit the growth of the base editing market. Because base editing may be so precise, it creates morality concerns about modifying the human genome. Strong regulations are necessary to ensure ethical utilization and address public worries. Base editing techniques have not yet been widely adopted, which has slowed down industry adoption and regulatory authorization systems. This is because it is difficult to strike an accurate compromise between promoting scientific advancement and protecting ethical concerns.

Regional Trends:

The North American base editing market is anticipated to register a remarkable market share in revenue. It is projected to grow at a high CAGR in the near future because of the supportive legislative systems, a thriving biomedical industry, and significant expenditures in scientific discovery. The region’s supremacy is further cemented by the existence of major industry participants and educational institutions actively involved in base editing breakthroughs. Besides, Europe had a considerable share of the market due to its rapidly expanding biotechnology sector and growing emphasis on personalized healthcare. The potential for base editing activities in the medicinal properties and investigation areas is improved by the legal structure in Europe being flexible enough to accommodate new technological advances.

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/enquiry-before-buying/2619

Recent Developments:

  • In Aug 2023, Pairwise and Bayer recently entered into a new five-year, multi-million dollar deal that specifically targets advancements in short-stature maize. Pairwise, a prominent food and agriculture company, is known for introducing the first gene-edited food to the U.S. market. This new program employed Pairwise’s Fulcrum™ platform and built upon the achievements of the firms’ previous five-year partnership in the cultivation of corn, soy, wheat, cotton, and canola. Annual partnership for the cultivation of corn, soy, wheat, cotton, and canola.

Segmentation of Base Editing Market-

By Product & Services

  • By Product
    • Platform
    • Reagents & Kits
    • Plasmids
    • Base Editing Libraries
    • By Service
      • gRNA Design
      • Cell Line Engineering
      • Other Services

By Type

  • DNA base editing
  • RNA base editing

By Targeted base

  • Cytosine base editing
  • Adenine base editing

By Application

  • Drug Discovery & Development
  • Agriculture
  • Veterinary

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2619

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Base Editing Market 2024: Trends, Innovations, and Growth Forecast

Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 billion by 2026

“ERCP Market by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) – Global Forecast to 2026”
North America accounted for the largest share of the ERCP market. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.

According to the new market research report “Endoscopic Retrograde Cholangiopancreatography/ERCP Market by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) – Global Forecast to 2026″, published by MarketsandMarkets™, the global Endoscopic Retrograde Cholangiopancreatography Market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170242954

The growth of this ERCP market is majorly attributed to factors such as the rising incidence of cancer, increasing investments by governments and healthcare organizations to improve endoscopy research, growing focus on investments by hospitals for advanced endoscopy instruments, and the increasing preference for minimally invasive surgeries. On the other hand, the high costs of endoscopic retrograde cholangiopancreatography devices, the development of other procedures like EUS and MRCP, and the shortage of trained physicians and endoscopists are factors expected to restrain the market growth to a certain extent.

By product type segment, the endotherapy devices segment accounted for the largest market share during the forecast period.

Based on products, the endoscopic retrograde cholangiopancreatography market has been segmented into endoscopes, endotherapy devices, visualization systems, energy devices, and others. The factors attributing to the large revenue of the endotherapy devices segment include the growing preference for minimally invasive surgeries and the increasing prevalence of gastrointestinal conditions.

Sphincterotomes accounted for the largest market share in the conventional devices segment during the forecast period.

In the endotherapy devices segment, sphincterotomes accounted for the largest market share during the forecast period. This can be attributed to the increasing incidence of pancreatic duct and bile duct stones and the growing geriatric population leading to an increase in biliary disorders.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170242954

North America dominates the endoscopic retrograde cholangiopancreatography market during the forecast period.

North America accounted for the largest share of the ERCP market in 2020. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.

The major players in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B. Braun Melsungen AG (Germany).

Other players in the endoscopic retrograde cholangiopancreatography market include Hobbs Medical, Inc. (US), STERIS PLC (US), Merit Medical Systems, Inc. (US), TeleMed Systems, Inc. (US), Changzhou Health Microport Medical Device Co., LTD. (China), Medi-Globe GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), Huger Medical Instrument Co., Ltd. (China), IntroMedic Co., Ltd. (Republic of Korea), SonoScape Medical Corporation (China), Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. (China), Ottomed (India), Kimberly-Clark Corporation (US), and Shaili Endoscopy (India)

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=170242954

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/endoscopic-retrograde-cholangiopancreatographyercp-market-worth-2-0-billion-by-2026–exclusive-report-by-marketsandmarkets-301504102.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 billion by 2026